Inhibition of Wnt and PI3K signaling modulates GSK-3β activity and induces morphological changes in cortical neurons: Role of tau phosphorylation

Neurochemical Research

Volumn 33, Issue 8, 2008, Pages 1599-1609

  Mercado Gómez, Octavio ^a   Hernández Fonseca, Karla ^b   Villavicencio Queijeiro, Alexa ^a   Massieu, Lourdes ^b   Chimal Monroy, Jesús ^a   Arias, Clorinda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Cortical neurons; Cytoskeleton; GSK 3 ; Lithium; PHF 1; Wnt inhibitors; Wortmannin

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; PHOSPHATIDYLINOSITOL 3 KINASE; TAU PROTEIN; WNT PROTEIN; WORTMANNIN;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CYTOSKELETON; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; MICROTUBULE; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TAUOPATHY; WISTAR RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALZHEIMER DISEASE; ANDROSTADIENES; ANIMALS; CELL SHAPE; CEREBRAL CORTEX; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEINS; HUMANS; MALE; MEMBRANE PROTEINS; NEURONS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TAU PROTEINS; WNT PROTEINS;

RATTUS;

EID: 46249120721     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9714-9     Document Type: Article

References (66)

1. Selkoe DJ (2000a) The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins. Neurol Clin 18:903-922
2. Selkoe DJ (2000b) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann NY Acad Sci 924:17-25
3. Iqbal K, Grundke-Iqbal I (2006) Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective. J Alzheimers Dis 9:219-242
4. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159
5. Ishiguro K, Shiratsuchi A, Sato S et al (1993) Glycogen synthase kinase 3 β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325:167-172
6. Lovestone S, Reynolds CH (1997) The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78:309-324
7. Pei JJ, Tanaka T, Tung YC et al (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70-78
8. Grimes CA, Jope RS (2001) CREB DNA binding activity is inhibited by glycogen synthase kinase-3 β and facilitated by lithium. J Neurochem 78:1219-1232
9. Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88
10. Chong ZZ, Maiese K (2004) Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol 19:495-504
11. Li F, Chong ZZ, Maiese K (2005) Vital elements of the Wnt-Frizzled signaling pathway in the nervous system. Curr Neurovasc Res 2:331-340
12. Salinas PC (1999) Wnt factors in axonal remodelling and synaptogenesis. Biochem Soc Symp 65:101-109
13. Lie DC, Colamarino SA, Song HJ et al (2005) Wnt signalling regulates adult hippocampal neurogenesis. Nature 437:1370-1375
14. Chen J, Park CS, Tang SJ (2006) Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem 281:11910-11916
15. Speese SD, Budnik V (2007) Wnts: up-and-coming at the synapse. Trends Neurosci 30:268-275
16. Cotter D, Kerwin R, al-Sarraji S et al (1998) Abnormalities of Wnt signalling in schizophrenia -evidence for neurodevelopmental abnormality. Neuroreport 9:1379-1383
17. Miyaoka T, Seno H, Ishino H (1999) Increased expression of Wnt-1 in schizophrenic brains. Schizophr Res 38:1-6
18. De Ferrari GV, Inestrosa NC (2000) Wnt signaling function in Alzheimer's disease. Brain Res Rev 33:1-12
19. Wehrli M, Dougan ST, Caldwell K et al (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature 407:527-530
20. Ikeda S, Kishida S, Yamamoto H et al (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17:1371-1384
21. Willert K, Nusse R (1998) β-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8:95-102
22. Dale TC (1998) Signal transduction by the Wnt family of ligands. Biochem J 329:209-223
23. Novak A, Dedhar S (1999) Signaling through β-catenin and Lef/Tcf. Cell Mol Life Sci 56:523-537
24. van Noort M, Clevers H (2002) TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 244:1-8
25. Rodgers EE, Theibert AB (2002) Functions of PI 3-kinase in development of the nervous system. Int J Dev Neurosci 20:187-197
26. Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305
27. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655-1657
28. Lucas FR, Salinas PC (1997) WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev Biol 192:31-44
29. Hall AC, Lucas FR, Salinas PC (2000) Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100:525-535
30. Rosso SB, Sussman D, Wynshaw-Boris A et al (2005) Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat Neurosci 8:34-42
31. Alvarez G, Muñoz-Montaño JR, Satrústegui J et al (1999) Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett 453:260-264
32. Garrido JL, Godoy JA, Alvarez A et al (2002) Protein kinase C inhibits amyloid β peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J 16:1982-1984
33. Alvarez AR, Godoy JA, Mullendorff K et al (2004) Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297:186-196
34. Caricasole A, Copani A, Caraci F et al (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J Neurosci 24:6021-6027
35. Scali C, Caraci F, Gianfriddo M et al (2006) Inhibition of Wnt signaling, modulation of tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiol Dis 24:254-265
36. Li X, Lu F, Tian Q et al (2006) Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture. J Neural Transm 113:93-102
37. Hernández-Fonseca K, Massieu L (2005) Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res 82:196-205
38. Brewer GJ, Torricelli JR, Evege EK et al (1993) Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free combination. J Neurosci Res 35:567-576
39. Gong CX, Lidsky T, Wegiel J et al (2001) Metabolically active rat brain slices as a model to study the regulation of protein phosphorylation in mammalian brain. Brain Res Protoc 6:134-140
40. Arias C, Arrieta I, Tapia R (1995) β-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. J Neurosci Res 41:561-566
41. Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627-2634
42. Jones SE, Jomary C (2002) Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays 24:811-820
43. Sperber BR, Leight S, Goedert M et al (1995) Glycogen synthase kinase-3 β phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett 197:149-153
44. Frame S, Cohen P (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359:1-16
45. Bhat RV, Budd Haeberlein SL, Avila J (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J Neurochem 89:1313-1317
46. Shaw M, Cohen P, Alessi DR (1997) Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett 416:307-311
47. Alger BE, Nicoll RA (1982) Feed-forward dendritic inhibition in rat hippocampal pyramidal cells studied in vitro. J Physiol 328:105-123
48. Inestrosa NC, Varela-Nallar L, Grabowski CP et al (2007) Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target. IUBMB Life 59:316-321
49. Caruso A, Motolese M, Iacovelli L et al (2006) Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J Neurochem 98:364-371
50. Welsh GI, Foultone EJ, Young SW et al (1994) Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem J 303:15-20
51. Morishima-Kawashima M, Hasegawa M, Takio K et al (1995) Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 270:823-829
52. Ryves WJ, Harwood AJ (2001) Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280:720-725
53. Atack JR (1997) Inositol monophosphatase inhibitors-lithium mimetics? Med Res Rev 17:215-224
54. Quiroz JA, Gould TD, Manji HK (2004) Molecular effects of lithium. Mol Interv 4:259-272
55. Chen G, Zeng WZ, Yuan PX et al (1999) The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72:879-882
56. Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664-1668
57. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci 93:8455-8459
58. Buée L, Bussière T, Buée-Scherrer V et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95-130
59. Liu SJ, Zhang AH, Li HL et al (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem 87:1333-1344
60. Lavie Y, Dybowski J, Agranoff BW (1997) Wortmannin blocks goldfish retinal phosphatidylinositol 3-kinase and neurite outgrowth. Neurochem Res 22:373-378
61. Sanchez S, Sayas CL, Lim F et al (2001) The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3. J Neurochem 78:468-481
62. Papasozomenos S, Binder LI (1987) Phosphorylation determines two distint species of tau in the central nervous system. Cell Motil Cytoskeleton 8:210-226
63. Arias C, Sharma N, Davies P et al (1993) Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. J Neurochem 61:673-682
64. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 87:554-567
65. Leroy K, Yilmaz Z, Brion JP (2007) Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33:43-55
66. Fukumoto S, Hsieh CM, Maemura K et al (2001) Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem 276:17479-17483